Navigation Links
Commercialization of nanotechnology

  • Dr Greg Smith, founder of SciVentures, an early stage venture capital investor who is keen to see passion in the eyes of his investees;
  • Dr. Paul McCormack, CEO of Perth based Advanced Nanotechnology, on the experience of taking nanotechnology research from the laboratory at the University of Western Australia to a listing on the Australian Stock exchange;
  • Dr Calum Drummond, Chief of the Division of Materials Science and Engineering at the Australia Government laboratory CSIRO, on the process of spinning out knowledge and IP from CSIRO into CAP-XX, a world leading producer of super capacitors;
  • Dr John Kapeleris, Deputy CEO of the Australian Institute of Commercialisation on ways nanotechnology commercialisation can be supported; and
  • Ms Tina Rankovic, CEO of the Australian Nano Business Forum, on the outlook for the nanotechnology industry in Australia.
  • Click here to listen to the podcast in full


    Contact: Ian Birkby

    Page: 1 2

    Related biology technology :

    1. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
    2. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
    3. ADVENTRX Appoints Vice President of Commercialization
    4. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
    5. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
    6. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
    7. NASA technology forms the basis for a new nanotechnology company
    8. Superbugs, shapes and nanotechnology
    9. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
    Post Your Comments:
    (Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
    (Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
    (Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
    (Date:10/7/2017)... , ... October 06, 2017 ... ... experience providing advanced instruments and applications consulting for microscopy and surface analysis, ... in application consulting, Nanoscience Analytical offers a broad range of contract analysis ...
    Breaking Biology Technology:
    (Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
    (Date:4/18/2017)... 18, 2017  Socionext Inc., a global expert in SoC-based imaging ... server, the M820, which features the company,s hybrid codec technology. A ... Tera Probe, Inc., will be showcased during the upcoming Medtec Japan ... at the Las Vegas Convention Center April ... Click here for ...
    (Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
    Breaking Biology News(10 mins):